T. Rowe Price Associates
MDRX

T. Rowe Price Associates’s Veradigm Inc. Common Stock MDRX Stock Holding History

T. Rowe Price Associates’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-64,696
Closed -$679K – 3000
2023
Q4 		$679K Buy
64,696
+7,330
+13% +$89.9K ﹤0.01% 2039
2023
Q3 		$754K Buy
57,366
+19,285
+51% +$253K ﹤0.01% 1926
2023
Q2 		$480K Buy
38,081
+1,194
+3% +$14.5K ﹤0.01% 2155
2023
Q1 		$482K Buy
36,887
+1,967
+6% +$31.9K ﹤0.01% 2124
2022
Q4 		$616K Sell
34,920
-7,620
-18% -$128K ﹤0.01% 2039
2022
Q3 		$648K Buy
42,540
+6,570
+18% +$106K ﹤0.01% 1995
2022
Q2 		$533K Buy
35,970
+15
+0% +$280 ﹤0.01% 2199
2022
Q1 		$810K Buy
35,955
+7,365
+26% +$149K ﹤0.01% 2109
2021
Q4 		$527K Sell
28,590
-32,666
-53% -$519K ﹤0.01% 2364
2021
Q3 		$819K Sell
61,256
-1,236
-2% -$20K ﹤0.01% 2144
2021
Q2 		$1.16M Sell
62,492
-1,396
-2% -$23.5K ﹤0.01% 2011
2021
Q1 		$959K Sell
63,888
-7,522
-11% -$120K ﹤0.01% 2070
2020
Q4 		$1.03M Buy
71,410
+14,038
+24% +$170K ﹤0.01% 1925
2020
Q3 		$467K Buy
57,372
+201
+0.4% +$1.64K ﹤0.01% 2116
2020
Q2 		$387K Buy
57,171
+499
+0.9% +$3.23K ﹤0.01% 2157
2020
Q1 		$399K Buy
56,672
+950
+2% +$7.71K ﹤0.01% 2083
2019
Q4 		$547K Buy
55,722
+6,328
+13% +$66.6K ﹤0.01% 2122
2019
Q3 		$542K Buy
49,394
+692
+1% +$7.1K ﹤0.01% 2066
2019
Q2 		$566K Buy
48,702
+348
+0.7% +$3.54K ﹤0.01% 2060
2019
Q1 		$461K Buy
48,354
+500
+1% +$5.52K ﹤0.01% 2143
2018
Q4 		$461K Buy
47,854
+288
+0.6% +$3.21K ﹤0.01% 2107
2018
Q3 		$678K Sell
47,566
-362
-0.8% -$4.92K ﹤0.01% 2023
2018
Q2 		$575K Buy
47,928
+198
+0.4% +$2.44K ﹤0.01% 2077
2018
Q1 		$589K Buy
47,730
+354
+0.7% +$5.03K ﹤0.01% 2021
2017
Q4 		$689K Sell
47,376
-34
-0.1% -$472 ﹤0.01% 1957
2017
Q3 		$675K Hold
47,410
– – ﹤0.01% 1962
2017
Q2 		$605K Buy
47,410
+55
+0.1% +$668 ﹤0.01% 1979
2017
Q1 		$600K Sell
47,355
-10,784
-19% -$128K ﹤0.01% 1991
2016
Q4 		$594K Buy
58,139
+19
+0% +$217 ﹤0.01% 1983
2016
Q3 		$765K Buy
58,120
+22,730
+64% +$304K ﹤0.01% 1847
2016
Q2 		$449K Hold
35,390
– – ﹤0.01% 2008
2016
Q1 		$468K Buy
35,390
+7,000
+25% +$91.9K ﹤0.01% 2000
2015
Q4 		$437K Buy
28,390
+5,590
+25% +$80.2K ﹤0.01% 2012
2015
Q3 		$283K Hold
22,800
– – ﹤0.01% 2161
2015
Q2 		$312K Hold
22,800
– – ﹤0.01% 2183
2015
Q1 		$273K Hold
22,800
– – ﹤0.01% 2232
2014
Q4 		$291K Sell
22,800
-5,700
-20% -$72.6K ﹤0.01% 2188
2014
Q3 		$382K Buy
+28,500
New +$432K ﹤0.01% 2051
2014
Q2 		– Sell
-30,100
Closed -$543K – 2553
2014
Q1 		$543K Hold
30,100
– – ﹤0.01% 1892
2013
Q4 		$465K Sell
30,100
-3,400
-10% -$50.1K ﹤0.01% 1942
2013
Q3 		$498K Hold
33,500
– – ﹤0.01% 1892
2013
Q2 		$433K Buy
+33,500
New +$449K ﹤0.01% 1912

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates's MDRX Position: Q1 2024 in Review

T. Rowe Price Associates sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 64,696 shares — an estimated $679K sold.

T. Rowe Price Associates first reported a position in MDRX in Q2 2013 and held it in 42 quarters. The position peaked at $1.16M in Q2 2021. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • T. Rowe Price Associates reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 64,696 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $679K.
  • T. Rowe Price Associates first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 42 quarters.
  • T. Rowe Price Associates's Veradigm Inc. Common Stock position peaked at $1.16M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.